• 1. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565
• 2. Excimer–monomer switch: a reaction-based approach for selective detection of fluoride?
  Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592
• 3. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 4. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 5. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Trifluoromethylbenzenes

Recent Advances in the Application of 244246-71-7 and 3-bromo-2-(trifluoromethyl)aniline in Chemical Biology and Pharmaceutical Research

The chemical compound with CAS number 244246-71-7 and the derivative 3-bromo-2-(trifluoromethyl)aniline have garnered significant attention in recent pharmaceutical and chemical biology research. These compounds serve as crucial intermediates in the synthesis of novel therapeutic agents and have demonstrated potential in various biomedical applications. This research briefing synthesizes the latest findings on their synthesis, mechanisms, and applications, providing a comprehensive overview for professionals in the field.

Recent studies have highlighted the role of 244246-71-7 as a versatile scaffold in drug discovery. Its unique chemical properties enable the development of targeted inhibitors for enzymes involved in inflammatory pathways. Meanwhile, 3-bromo-2-(trifluoromethyl)aniline has been extensively studied for its utility in constructing complex molecules, particularly in the synthesis of agrochemicals and pharmaceuticals. Advanced spectroscopic techniques and computational modeling have been employed to elucidate its reactivity and stability under various conditions.

One of the groundbreaking applications of these compounds is in the development of kinase inhibitors. Researchers have successfully incorporated 3-bromo-2-(trifluoromethyl)aniline into the core structure of several kinase inhibitors, enhancing their selectivity and potency. In vitro and in vivo studies have shown promising results, with reduced off-target effects compared to traditional inhibitors. These findings underscore the potential of these compounds in next-generation therapeutics.

Moreover, the environmental impact and safety profiles of these compounds have been a focal point of recent investigations. Studies utilizing high-performance liquid chromatography (HPLC) and mass spectrometry have confirmed their biodegradability and low toxicity, making them suitable candidates for large-scale pharmaceutical production. Regulatory assessments are currently underway to evaluate their compliance with international safety standards.

In conclusion, the ongoing research on 244246-71-7 and 3-bromo-2-(trifluoromethyl)aniline highlights their pivotal role in advancing chemical biology and pharmaceutical sciences. Their applications span from drug development to agrochemical innovation, supported by robust scientific evidence. Future studies are expected to explore their potential in emerging therapeutic areas, further solidifying their importance in the field.

• 232267-31-1(3-Bromo-2-methyl-5-(trifluoromethyl)aniline)
• 1445995-83-4(4-Bromo-3-(Trifluoromethyl)Benzene-1,2-Diamine 90%)
• 703-91-3(5-Bromo-2-(trifluoromethyl)aniline)
• 1805123-75-4(3,5-Dibromo-2-(trifluoromethyl)aniline)
• 1807107-41-0(Benzenamine, 4-bromo-2-methyl-5-(trifluoromethyl)-)
• 77992-50-8(Benzenamine, 4-bromo-3-(trifluoromethyl)-, hydrochloride)
• 62202-39-5(3-bromo-4-(trifluoromethyl)aniline hydrochloride)
• 1806274-43-0(3,5-Dibromo-4-(trifluoromethyl)aniline)
• 1804866-39-4(4-Amino-2-bromo-3-(trifluoromethyl)benzylamine)
• 172215-91-7(3-Bromo-4-(trifluoromethyl)aniline)